Results 31 to 40 of about 41,337 (280)

Schematic illustration for MPN-HBP1-mediated anticancer therapy.

, 2023
The PEI-HBP1 coordinates with tannic acid and ferric ions to form MPN-HBP1. After MPN-HBP1 nanoparticles reach the tumor site via passive targeting, the tannic acid and ferric ions in the MPN coating enhance the Fenton reaction to induce ferroptosis in ...
Xiaowei Zhang (6505), Jiyin Wang (10453367), Yue Zhou (71752), Ruixiang Yang (10453370), Shujie Wang (750318), Yuning Cheng (9303610), Tongjia Zhang (16496661), Zhe Yang (8942), Hui Li (32376), Wei Jiang (14986)   +9 more
core   +1 more source

Changes in the indices of prooxidant and antioxidant systems in blood plasma in men with atrophic gastritis and gastric cancer [PDF]

Терапевтический архив, 2018
Aim. To study changes in the indices of prooxidant and antioxidant systems in plasma in men with atrophic gastritis and gastric cancer. Materials and methods.
V V Tsukanov, O V Smirnova, E V Kasparov, A A Sinyakov, A V Vasyutin, Yu L Tonkikh   +5 more
doaj   +1 more source

Clinical Discernment, Bone Marrow, and Molecular Diagnostics Are Equally Important to Solve the Phenotypic Mimicry among Subtypes of Myeloproliferative Neoplasms

Reports, 2021
The 2016 WHO classification integrates clinical, bone marrow (BM)-morphology, and molecular features to define disease entities. This together with the advancements in molecular detection and standardization of BM features enable an accurate diagnosis of
Susann Schulze, Nadia Jaekel, Christin Le Hoa Naumann, Anja Haak, Marcus Bauer, Claudia Wickenhauser, Haifa Kathrin Al-Ali   +6 more
doaj   +1 more source

Complications after medullary thyroid carcinoma surgery: multicentre study of the SQRTPA and EUROCRINE® databases

BJS (British Journal of Surgery), EarlyView., 2020
This study investigated postoperative complications after surgery for medullary thyroid carcinoma (MTC) in Europe. Hypoparathyroidism, recurrent laryngeal nerve palsy and bleeding requiring reoperation occurred in 170 (26·2 per cent), 62 (13·7 per cent) and 17 (2·6 per cent) patients respectively.
D.‐J. van Beek, M. Almquist, A. O. Bergenfelz, T. J. Musholt, E. Nordenström, on behalf of the EUROCRINE® Council, M. Almquist, M. Barczynski, L. Brunaud, T. Clerici, M. H. Hansen, M. Iacobone, Ö. Makay, F. F. Palazzo, N. Muñoz‐Pérez, M. Raffaelli, P. Riss, S. van Slycke, M. R. Vriens   +18 more
wiley   +1 more source

Clinical characteristics and symptom burden of Thai myeloproliferative neoplasm patients

Hematology, 2023
Objective Patients living with myeloproliferative neoplasms (MPNs) suffer from symptom burden that affect quality of life. Due to the differences in cultures, climates, and genetic background, we aimed to investigate the symptom burden of Thai MPN ...
Naritsara Cherdchoo, Chantana Polprasert, Ponlapat Rojnuckarin, Sunisa Kongkiatkamon   +3 more
doaj   +1 more source

Clinicopathological characterisation of myeloproliferative neoplasm‐unclassifiable (MPN‐U): a retrospective analysis from a large UK tertiary referral centre

, 2021
Myeloproliferative neoplasm-unclassifiable (MPN-U) presents an MPN-type phenotype that fails to meet diagnostic criteria for other MPN variants. Variability in the clinicopathological phenotypes presents many challenges. Amongst a registry cohort of 1512
Patrick Harrington, Yvonne Francis, Curto-Garcia, Natalia, Francis, Yvonne, O'Sullivan, Jennifer, Sarah Bassiony, Deschamps, Paul, Claire Woodley, Moonim, Mufaddal, McLornan, Donal P., Natalia Curto‐Garcia, Harrison, Claire N., Jennifer O'Sullivan, Kordasti, Shahram; id_orcid, Paul Deschamps, Donal P. McLornan, Harrington, Patrick, Claire N. Harrison, Mufaddal Moonim, Woodley, Claire, Raj, Kavita, Radia, Deepti, Bassiony, Sarah, Shahram Kordasti, Kavita Raj, Deepti Radia, Ali, Sahra, Sahra Ali, Curto-Garcia N., Moonim M., Kordasti S., Deschamps P., Ali S., Harrison C. N., O'Sullivan J., Woodley C., Harrington P., McLornan D. P., Bassiony S., Radia D., Francis Y., Raj K.   +41 more
core   +2 more sources

Recurrent bilateral adrenal infarction with myelodysplastic/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U): a case report

, 2023
Background Bilateral adrenal infarction is rare and only a small number of cases have been reported so far. Adrenal infarction is usually caused by thrombophilia or a hypercoagulable state, such as antiphospholipid antibody syndrome, pregnancy, and ...
Yui Asatsuma, Nobuaki Ito, Junichiro Sato, Yoshitomo Hoshino, Hirofumi Horikoshi, Masaomi Nangaku, Megumi Yasunaga, Akira Honda, Kensuke Matsuda, Hiroaki Maki, Katsunori Manaka, Megumi Fujita, Yosuke Masamoto, Mineo Kurokawa, Maki Takeuchi, Noriko Makita   +15 more
core   +1 more source

Laboratory Investigation of Myeloproliferative Neoplasms (MPNs) [PDF]

American Journal of Clinical Pathology, 2016
To standardize diagnostic investigations for myeloproliferative neoplasms (MPNs) to increase homogeneity in patient care and to streamline diagnostic approaches in the most efficient and cost-effective manner.The development of Canadian expert consensus recommendations for the diagnosis of MPNs began with a review of the following: clinical evidence ...
Lambert, Busque, Anna, Porwit, Radmila, Day, Harold J, Olney, Brian, Leber, Vincent, Éthier, Shireen, Sirhan, Linda, Foltz, Jaroslav, Prchal, Suzanne, Kamel-Reid, Aly, Karsan, Vikas, Gupta   +11 more
openaire   +2 more sources

MPN Patient characteristics.

, 2015
AML–Acute Myeloid Leukaemia; PV–Polycythaemia Vera; ET–Essential Thrombocytosis; MPN-U—Myeloproliferative Neoplasm–Unclassified; MPN-CEL/HES—Myeloproliferative Neoplasm with chronic eosinophilic leukemia/hypereosinophilic syndrome; F–Female; M–Male; n.d.–
António M. Almeida (832215), Hélio Belo (104574), João T. Barata (263904), Bruno A. Cardoso (104572)   +3 more
core   +1 more source

The nanoparticles MPN-HBP1 was designed to kill cancer cells via ferroptosis pathway.

, 2023
(A) MPN-HBP1 dissociation by EDTA, NaCl, urea, and Tween 20. MPN-HBP1 was effectively dissociated by EDTA due to complexation competition. (B) HBP1, GPX4, ACSL4, and TFRC protein levels of PBS, PEI-HBP1, and MPN-HBP1 treated HeLa cells.
Xiaowei Zhang (6505), Jiyin Wang (10453367), Yue Zhou (71752), Ruixiang Yang (10453370), Shujie Wang (750318), Yuning Cheng (9303610), Tongjia Zhang (16496661), Zhe Yang (8942), Hui Li (32376), Wei Jiang (14986)   +9 more
core   +1 more source